Janet Freeman-Daily on Genomic Testing for Lung Cancer Patients

Janet Freeman-Daily, a patient with metastatic lung cancer and a CURE contributor, discusses the importance of genomic testing for patients with lung cancer.

BY Janet Freeman-Daily

PUBLISHED July 27, 2015

Janet Freeman-Daily, a patient with metastatic lung cancer and a CURE contributor, discusses the importance of genomic testing for patients with lung cancer. We spoke with Freeman-Daily during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of nearly 30,000 oncology professionals in Chicago.